ARTICLE | Clinical News
TheraTech Inc, Procter and Gamble Co. regulatory update
January 2, 1996 8:00 AM UTC
THRT filed an NDA with the FDA for its estradiol transdermal patch as a hormone replacement therapy. The patch uses THRT's matrix transdermal technology to deliver the hormone continuously for up to f...